RON LEE: Open Payments
NPI 1376572800 · PRAIRIE GROVE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 50 payments from 11 companies in 2025. Trend: 2023 $1,084 · 2024 $897 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $283 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $211 |
| ABBVIE INC. | 15 | $203 |
| Novo Nordisk Inc | 5 | $80 |
| PFIZER INC. | 4 | $76 |
| Amgen Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
Products named: AIRSUPRA, Kerendia, QULIPTA, UBRELVY, Rybelsus, NURTEC ODT, MOUNJARO, OTEZLA.
Industry payments across AR — which companies pay providers there.
